Evidence map›Paper›PMID 27220549›Full record

ArticleMolecular medicine reports2016

Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model.

Zhai Yang, Qiong Jiang, Shuang-Xi Chen, Cheng-Liang Hu, Hui-Fan Shen, Pei-Zhi Huang, Jun-Ping Xu, Jin-Ping Mei, Ben-Ping Zhang, Wei-Jiang Zhao

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nrg1 Intracellular Signaling Is Neuroprotective upon Stroke.Oxidative medicine and cellular longevity · 2019
    Article
  5. Neuregulin in Health and Disease.International journal of brain disorders and treatment · 2018
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zhai YangCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Qiong JiangCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Shuang-Xi ChenCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Cheng-Liang HuCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Hui-Fan ShenCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Pei-Zhi HuangCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Jun-Ping XuCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Jin-Ping MeiGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China.
Ben-Ping ZhangDepartment of Neurology, The 2nd Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
Wei-Jiang ZhaoCenter for Neuroscience, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Shantou University · CNHarbin Medical University · CNTianjin University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuregulin 1 (Nrg1) is involved in multiple biological processes in the nervous system. The present study investigated changes in Nrg1 signaling in the major brain regions of mice subjected to lipopolysaccharide (LPS)-induced neuroinflammation. At 24 h post‑intraperitoneal injection of LPS, mouse brain tissues, including tissues from the cortex, striatum, hippocampus and hypothalamus, were collected. Reverse transcription‑polymerase chain reaction was used to determine the expression of Nrg1 and its receptors, Neu and ErbB4, at the mRNA level. Western blotting was performed to determine the levels of these proteins and the protein levels of phosphorylated extracellular signal-regulated kinases (Erk)1/2 and Akt1. Immunohistochemical staining was utilized to detect the levels of pNeu and pErbB4 in these regions. LPS successfully induced sites of neuroinflammation in these regions, in which changes in Nrg1, Neu and ErbB4 at the mRNA and protein levels were identified compared with controls. LPS induced a reduction in pNeu and pErbB4 in the striatum and hypothalamus, although marginally increased pErbB4 levels were found in the hippocampus. LPS increased the overall phosphorylation of Src but this effect was reduced in the hypothalamus. Moreover, increased phosphorylation of Akt1 was found in the striatum and hippocampus. These data suggest diverse roles for Nrg1 signaling in these regions during the process of neuroinflammation.

Indexed as

Signal TransductionAnimalsBrainDisease Models, AnimalEncephalitisErb-b2 Receptor Tyrosine KinasesFemaleGene ExpressionImmunohistochemistryLipopolysaccharidesMiceNeuregulin-1PhosphorylationProto-Oncogene Proteins c-aktReceptor, ErbB-4Erb-b2 Receptor Tyrosine KinasesLipopolysaccharidesNeuregulin-1Proto-Oncogene Proteins c-aktReceptor, ErbB-4

Identifiers

PMID27220549
PMCPMC4918623
OpenAlexW2401407683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.